Drug
Adapalene Benzoyl Peroxide
Adapalene Benzoyl Peroxide: highest development phase Post-Market, developed by Galderma. 3 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Galderma
Trials
| Drug | Phase | Indication |
|---|---|---|
| adapalene/benzoyl peroxide NCT01138735 | Post-Market | Acne |
| Adapalene/benzoyl peroxide gel, 0.1%/2.5% NCT02249104 | Post-Market | Acne Vulgaris |
| Adapalene/Benzoyl Peroxide NCT00422240 | Phase 3 | Acne Vulgaris |
Latest
No recent events.
Follow Adapalene Benzoyl Peroxide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.